Medscape Medical NewsAll articles

PowerLook Density Assessment V4.0

iCAD, Inc. • Radiology • 07/12/2021

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

PowerLook Density Assessment V4.0 is an adjunctive software application that automatically analyzes synthetic 2D images derived from Digital Breast Tomosynthesis (DBT) exams to provide a BI-RADS 5th Edition breast density category, aiding healthcare professionals in assessing breast tissue composition. The system employs a new, independently developed algorithm running on the PowerLook AMP platform, processing DICOM data from compatible Hologic and GE DBT systems to deliver consistent density assessments, including for GE V-Preview V4.1 data.

Summary

PowerLook Density Assessment V4.0 is a software application developed by iCAD, Inc., designed to assist healthcare professionals in evaluating breast tissue composition. It processes synthetic 2D images generated from Digital Breast Tomosynthesis (DBT) mammography exams, specifically those containing up to four such views, using an algorithm to assess these images and assign a breast density category according to the BI-RADS® 5th Edition lexicon. This tool provides adjunctive information, not a diagnostic aid, and is intended to support radiologists in their interpretation process. The V4.0 iteration features a new custom software application designed for the PowerLook AMP platform and includes validated support for GE V-Preview V4.1 images, distinguishing it as a new and independent application from its predecessor, V3.4. The software integrates with iCAD’s PowerLook DICOM server platform (PowerLook AMP) for managing data input and output. The results, which include the BI-RADS category and a 'fractional indication of distance inside breast density category,' can be displayed on mammography review workstations, mammography reporting applications, radiology information systems (RIS), or printed case reports. PowerLook Density Assessment V4.0 is compatible with specific DBT systems, namely Hologic Selenia Dimensions/3Dimensions (C-View), GE Senographe Essential with SenoClaire (V-Preview), and GE Senographe Pristina (V-Preview). Non-clinical performance data from verification and validation testing, including unit, integration, and regression testing on Hologic C-View, GE V-Preview V3, and GE V-Preview V4.1 cases, demonstrated that the system accurately calculates the BI-RADS breast density category for these datasets.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

PowerLook Density AssessmentBreast DensityBI-RADSDigital Breast TomosynthesisSynthetic 2D ImagesMammographySoftware AlgorithmImage ProcessingDICOMAdjunctive Information

Device Metadata

Submission Number
K211506
Company
iCAD, Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the performance of PowerLook Density Assessment V4.0, specifically its accuracy in BI-RADS categorization, compare when processing synthetic 2D images from different DBT vendor systems (Hologic C-View, GE V-Preview) and varying image acquisition parameters?; What are the specific algorithmic differences in V4.0 compared to V3.4, particularly in its ability to process GE V-Preview V4.1 data, and how do these changes affect the precision of density boundary determination within BI-RADS categories?; What is the clinical utility and impact of the 'fractional indication of distance inside breast density category' output, and how does it influence radiologist confidence or subsequent patient management recommendations compared to a simple BI-RADS category assignment?; Are there known limitations or types of breast tissue characteristics (e.g., presence of implants, extensive calcifications, architectural distortion) where PowerLook Density Assessment V4.0's accuracy might be compromised, and what are the recommended workflows in such scenarios?; How does the integration of PowerLook Density Assessment V4.0 with the PowerLook AMP platform affect workflow efficiency and data integrity in a typical radiology practice, and what are the system requirements for optimal performance?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
PowerLook Density Assessment V4.0 - iCAD, Inc. | ESL FDA AI Device Intelligence